Report Detail

Pharma & Healthcare Global Oral Codeine Tablet Market Growth 2022-2028

  • RnM4389783
  • |
  • 04 March, 2022
  • |
  • Global
  • |
  • 111 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

As the global economy mends, the 2021 growth of Oral Codeine Tablet will have significant change from previous year. According to our (LP Information) latest study, the global Oral Codeine Tablet market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oral Codeine Tablet market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Oral Codeine Tablet market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Oral Codeine Tablet market, reaching US$ million by the year 2028. As for the Europe Oral Codeine Tablet landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Oral Codeine Tablet players cover Taiji, Mallinckrodt, TEVA, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Codeine Tablet market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Single-ingredient Codeine
Multi-ingredient Medications

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Narcotic Analgesic
Antitussive
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Oral Codeine Tablet Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Oral Codeine Tablet by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Oral Codeine Tablet by Country/Region, 2017, 2022 & 2028
  • 2.2 Oral Codeine Tablet Segment by Type
    • 2.2.1 Single-ingredient Codeine
    • 2.2.2 Multi-ingredient Medications
  • 2.3 Oral Codeine Tablet Sales by Type
    • 2.3.1 Global Oral Codeine Tablet Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Oral Codeine Tablet Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Oral Codeine Tablet Sale Price by Type (2017-2022)
  • 2.4 Oral Codeine Tablet Segment by Application
    • 2.4.1 Narcotic Analgesic
    • 2.4.2 Antitussive
    • 2.4.3 Others
  • 2.5 Oral Codeine Tablet Sales by Application
    • 2.5.1 Global Oral Codeine Tablet Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Oral Codeine Tablet Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Oral Codeine Tablet Sale Price by Application (2017-2022)

3 Global Oral Codeine Tablet by Company

  • 3.1 Global Oral Codeine Tablet Breakdown Data by Company
    • 3.1.1 Global Oral Codeine Tablet Annual Sales by Company (2020-2022)
    • 3.1.2 Global Oral Codeine Tablet Sales Market Share by Company (2020-2022)
  • 3.2 Global Oral Codeine Tablet Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Oral Codeine Tablet Revenue by Company (2020-2022)
    • 3.2.2 Global Oral Codeine Tablet Revenue Market Share by Company (2020-2022)
  • 3.3 Global Oral Codeine Tablet Sale Price by Company
  • 3.4 Key Manufacturers Oral Codeine Tablet Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Oral Codeine Tablet Product Location Distribution
    • 3.4.2 Players Oral Codeine Tablet Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oral Codeine Tablet by Geographic Region

  • 4.1 World Historic Oral Codeine Tablet Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Oral Codeine Tablet Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Oral Codeine Tablet Annual Revenue by Geographic Region
  • 4.2 World Historic Oral Codeine Tablet Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Oral Codeine Tablet Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Oral Codeine Tablet Annual Revenue by Country/Region
  • 4.3 Americas Oral Codeine Tablet Sales Growth
  • 4.4 APAC Oral Codeine Tablet Sales Growth
  • 4.5 Europe Oral Codeine Tablet Sales Growth
  • 4.6 Middle East & Africa Oral Codeine Tablet Sales Growth

5 Americas

  • 5.1 Americas Oral Codeine Tablet Sales by Country
    • 5.1.1 Americas Oral Codeine Tablet Sales by Country (2017-2022)
    • 5.1.2 Americas Oral Codeine Tablet Revenue by Country (2017-2022)
  • 5.2 Americas Oral Codeine Tablet Sales by Type
  • 5.3 Americas Oral Codeine Tablet Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Oral Codeine Tablet Sales by Region
    • 6.1.1 APAC Oral Codeine Tablet Sales by Region (2017-2022)
    • 6.1.2 APAC Oral Codeine Tablet Revenue by Region (2017-2022)
  • 6.2 APAC Oral Codeine Tablet Sales by Type
  • 6.3 APAC Oral Codeine Tablet Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Oral Codeine Tablet by Country
    • 7.1.1 Europe Oral Codeine Tablet Sales by Country (2017-2022)
    • 7.1.2 Europe Oral Codeine Tablet Revenue by Country (2017-2022)
  • 7.2 Europe Oral Codeine Tablet Sales by Type
  • 7.3 Europe Oral Codeine Tablet Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Oral Codeine Tablet by Country
    • 8.1.1 Middle East & Africa Oral Codeine Tablet Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Oral Codeine Tablet Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Oral Codeine Tablet Sales by Type
  • 8.3 Middle East & Africa Oral Codeine Tablet Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Oral Codeine Tablet
  • 10.3 Manufacturing Process Analysis of Oral Codeine Tablet
  • 10.4 Industry Chain Structure of Oral Codeine Tablet

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Oral Codeine Tablet Distributors
  • 11.3 Oral Codeine Tablet Customer

12 World Forecast Review for Oral Codeine Tablet by Geographic Region

  • 12.1 Global Oral Codeine Tablet Market Size Forecast by Region
    • 12.1.1 Global Oral Codeine Tablet Forecast by Region (2023-2028)
    • 12.1.2 Global Oral Codeine Tablet Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Oral Codeine Tablet Forecast by Type
  • 12.7 Global Oral Codeine Tablet Forecast by Application

13 Key Players Analysis

  • 13.1 Taiji
    • 13.1.1 Taiji Company Information
    • 13.1.2 Taiji Oral Codeine Tablet Product Offered
    • 13.1.3 Taiji Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Taiji Main Business Overview
    • 13.1.5 Taiji Latest Developments
  • 13.2 Mallinckrodt
    • 13.2.1 Mallinckrodt Company Information
    • 13.2.2 Mallinckrodt Oral Codeine Tablet Product Offered
    • 13.2.3 Mallinckrodt Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Mallinckrodt Main Business Overview
    • 13.2.5 Mallinckrodt Latest Developments
  • 13.3 TEVA
    • 13.3.1 TEVA Company Information
    • 13.3.2 TEVA Oral Codeine Tablet Product Offered
    • 13.3.3 TEVA Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 TEVA Main Business Overview
    • 13.3.5 TEVA Latest Developments
  • 13.4 Johnson & Johnson
    • 13.4.1 Johnson & Johnson Company Information
    • 13.4.2 Johnson & Johnson Oral Codeine Tablet Product Offered
    • 13.4.3 Johnson & Johnson Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Johnson & Johnson Main Business Overview
    • 13.4.5 Johnson & Johnson Latest Developments
  • 13.5 Medreich
    • 13.5.1 Medreich Company Information
    • 13.5.2 Medreich Oral Codeine Tablet Product Offered
    • 13.5.3 Medreich Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Medreich Main Business Overview
    • 13.5.5 Medreich Latest Developments
  • 13.6 Sanofi Aventis
    • 13.6.1 Sanofi Aventis Company Information
    • 13.6.2 Sanofi Aventis Oral Codeine Tablet Product Offered
    • 13.6.3 Sanofi Aventis Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Sanofi Aventis Main Business Overview
    • 13.6.5 Sanofi Aventis Latest Developments
  • 13.7 Cipla
    • 13.7.1 Cipla Company Information
    • 13.7.2 Cipla Oral Codeine Tablet Product Offered
    • 13.7.3 Cipla Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Cipla Main Business Overview
    • 13.7.5 Cipla Latest Developments
  • 13.8 Hikma
    • 13.8.1 Hikma Company Information
    • 13.8.2 Hikma Oral Codeine Tablet Product Offered
    • 13.8.3 Hikma Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Hikma Main Business Overview
    • 13.8.5 Hikma Latest Developments
  • 13.9 Pharmaceutical Associates
    • 13.9.1 Pharmaceutical Associates Company Information
    • 13.9.2 Pharmaceutical Associates Oral Codeine Tablet Product Offered
    • 13.9.3 Pharmaceutical Associates Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Pharmaceutical Associates Main Business Overview
    • 13.9.5 Pharmaceutical Associates Latest Developments
  • 13.10 Novartis
    • 13.10.1 Novartis Company Information
    • 13.10.2 Novartis Oral Codeine Tablet Product Offered
    • 13.10.3 Novartis Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Novartis Main Business Overview
    • 13.10.5 Novartis Latest Developments
  • 13.11 Apotex
    • 13.11.1 Apotex Company Information
    • 13.11.2 Apotex Oral Codeine Tablet Product Offered
    • 13.11.3 Apotex Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Apotex Main Business Overview
    • 13.11.5 Apotex Latest Developments
  • 13.12 Mylan
    • 13.12.1 Mylan Company Information
    • 13.12.2 Mylan Oral Codeine Tablet Product Offered
    • 13.12.3 Mylan Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Mylan Main Business Overview
    • 13.12.5 Mylan Latest Developments
  • 13.13 Aristo Pharma GmbH
    • 13.13.1 Aristo Pharma GmbH Company Information
    • 13.13.2 Aristo Pharma GmbH Oral Codeine Tablet Product Offered
    • 13.13.3 Aristo Pharma GmbH Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Aristo Pharma GmbH Main Business Overview
    • 13.13.5 Aristo Pharma GmbH Latest Developments
  • 13.14 Lannett Company
    • 13.14.1 Lannett Company Company Information
    • 13.14.2 Lannett Company Oral Codeine Tablet Product Offered
    • 13.14.3 Lannett Company Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Lannett Company Main Business Overview
    • 13.14.5 Lannett Company Latest Developments
  • 13.15 Laboratoire Riva
    • 13.15.1 Laboratoire Riva Company Information
    • 13.15.2 Laboratoire Riva Oral Codeine Tablet Product Offered
    • 13.15.3 Laboratoire Riva Oral Codeine Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 Laboratoire Riva Main Business Overview
    • 13.15.5 Laboratoire Riva Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Oral Codeine Tablet. Industry analysis & Market Report on Oral Codeine Tablet is a syndicated market report, published as Global Oral Codeine Tablet Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Oral Codeine Tablet market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,829.18
5,658.36
3,407.46
6,814.92
558,845.40
1,117,690.80
308,904.00
617,808.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report